{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:55:36Z","timestamp":1793012136863,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006752","name":"Universidade do Porto","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006752","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Growing Teratoma Syndrome (GTS) is a rare entity occurring in patients with non-seminomatous germ cell tumours (NSGCT) following chemotherapy. GTS is resistant to chemotherapy and radiotherapy, making retroperitoneal lymph node dissection (RPLND) the mainstay of treatment. This review aims to synthesize evidence on the surgical management and oncological outcomes of retroperitoneal GTS.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted in accordance with PRISMA guidelines and registered in PROSPERO (CRD420251233173). PubMed and Embase were searched from inception to November 2025. Risk of bias was assessed using the ROBINS-I tool.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifteen studies comprising 156 patients with NSGCT-associated retroperitoneal GTS treated with RPLND were included. The reported incidence ranged from 2.8% to 7.6%. Median patient age across studies was 16\u201338 years. Mixed NSGCT was present in 73\u2013100% of orchidectomy specimens, with a teratoma component identified in 40\u2013100%. The interval to RPLND ranged from 2 to 30 months and median operative time ranged from 160 to 432\u00a0min, and estimated blood loss from 225 to 2500 mL. Adjunctive procedures were required in 10\u2013100% of patients, and postoperative complications occurred in 12.5\u201344%, with Clavien-Dindo\u2009\u2265\u2009III complications in 12.5\u201325%. Median length of hospital stay ranged from 5 to 15 days. Disease-free survival varied between 41.7% and 100%, and overall survival between 73.7% and 100% with follow-up ranging from 8 to 103 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>RPLND is a complex procedure with effective oncological outcomes for GTS. Multicentric registries are needed for generating high-quality standardised data.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00345-026-06207-5","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T07:52:19Z","timestamp":1768290739000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Retroperitoneal lymph node dissection for growing teratoma syndrome in testicular cancer: a systematic review of surgical outcomes"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6753-7206","authenticated-orcid":false,"given":"Alberto","family":"Costa Silva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afonso","family":"Morgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Alturas Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noel","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Almeida Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aziz","family":"Gulamhusein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"issue":"8","key":"6207_CR1","doi-asserted-by":"publisher","first-page":"1629","DOI":"10.1002\/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1","volume":"50","author":"CJ Logothetis","year":"1982","unstructured":"Logothetis CJ, Samuels ML, Trindade A, Johnson DE (1982) The growing teratoma syndrome. Cancer, 50(8):1629\u20131635. 10.1002\/1097-0142(19821015)50:8<1629::AID-CNCR2820500828>3.0.CO;2-1","journal-title":"Cancer"},{"key":"6207_CR2","doi-asserted-by":"crossref","unstructured":"Jeffery GM, Theaker JM, Lee AHS, Blaquiere RM, Smartand CJ, Mead GM (1991) The growing teratoma syndrome ; volume 61, pages 195-202 , DOI 10.1111\/j.1464-410x.1991.tb15109.x","DOI":"10.1111\/j.1464-410X.1991.tb15109.x"},{"key":"6207_CR3","doi-asserted-by":"publisher","unstructured":"Salzillo C et al (2024) Gonadal teratomas: a state-of-the-art review in pathology. Multidisciplinary Digital Publishing Institute (MDPI) https:\/\/doi.org\/10.3390\/cancers16132412","DOI":"10.3390\/cancers16132412"},{"key":"6207_CR4","doi-asserted-by":"publisher","unstructured":"Hiester A, Nettersheim D, Nini A, Lusch A, Albers P (2019) Management, treatment, and molecular background of the growing teratoma syndrome. https:\/\/doi.org\/10.1016\/j.ucl.2019.04.008","DOI":"10.1016\/j.ucl.2019.04.008"},{"key":"6207_CR5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.i4919","author":"JA Sterne","year":"2016","unstructured":"Sterne JA et al (2016) ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ"},{"key":"6207_CR6","doi-asserted-by":"crossref","unstructured":"Tonkin KS, Rustin GJS, Wignall B, Paradinas F, Bennett+ M (1989) Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. European Journal of Cancer, Volume 25, Issue 12 , page 1739-1743 ;10.1016\/0277-5379(89)90343-X","DOI":"10.1016\/0277-5379(89)90343-X"},{"key":"6207_CR7","doi-asserted-by":"publisher","unstructured":"Tongaonkar H 6, Deshmane VH, Dalal AV, Kulkarni JN, Kamat MR (1994) Growing teratoma syndrome , Journal of Surgical Oncology 55:56-60 (1994) ,https:\/\/doi.org\/10.1002\/jso.2930550116","DOI":"10.1002\/jso.2930550116"},{"issue":"4","key":"6207_CR8","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1159\/000282793","volume":"55","author":"R Ravi","year":"1995","unstructured":"Ravi R (1995) Growing teratoma syndrome. Urol Int 55(4):226\u2013228. 0042-1138\/95\/0554-0226$8.00\/0","journal-title":"Urol Int"},{"key":"6207_CR9","doi-asserted-by":"crossref","unstructured":"Maroto P et al (1997) Growing teratoma syndrome: experience of a single institution. European Urology, volume 32, pages 305-309 , DOI 0302-2838\/97\/0323-0305$ 12.00\/0","DOI":"10.1159\/000480830"},{"key":"6207_CR10","doi-asserted-by":"crossref","unstructured":"Andre F et al The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. volume 36, page 1389-1394 , DOI: 10.1016\/s0959-8049(00)00137-4","DOI":"10.1016\/S0959-8049(00)00137-4"},{"issue":"4","key":"6207_CR11","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1016\/j.juro.2006.11.086","volume":"177","author":"PE Spiess","year":"2007","unstructured":"Spiess PE et al (2007) Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol 177(4):1330\u20131334 https:\/\/doi.org\/10.1016\/j.juro.2006.11.086","journal-title":"J Urol"},{"issue":"2","key":"6207_CR12","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.urology.2011.08.076","volume":"79","author":"M Stella","year":"2012","unstructured":"Stella M et al (2012) Retroperitoneal vascular surgery for the treatment of giant growing teratoma syndrome. Urology 79(2):365\u2013370 https:\/\/doi.org\/10.1016\/j.urology.2011.08.076","journal-title":"Urology"},{"issue":"9","key":"6207_CR13","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/iju.12466","volume":"21","author":"DJ Lee","year":"2014","unstructured":"Lee DJ et al (2014) Growing teratoma syndrome: clinical and radiographic characteristics. Int J Urol 21(9):905\u2013908. https:\/\/doi.org\/10.1111\/iju.12466","journal-title":"Int J Urol"},{"issue":"12","key":"6207_CR14","doi-asserted-by":"publisher","first-page":"529.e23","DOI":"10.1016\/j.urolonc.2018.09.012","volume":"36","author":"P Paffenholz","year":"2018","unstructured":"Paffenholz P, Pfister D, Matveev V, Heidenreich A (2018) Diagnosis and management of the growing teratoma syndrome: a single-center experience and review of the literature. Urol Oncol. 36(12):529.e23-529.e30 https:\/\/doi.org\/10.1016\/j.urolonc.2018.09.012","journal-title":"Urol Oncol"},{"issue":"2","key":"6207_CR15","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1155\/2014\/139425","volume":"15","author":"A Scavuzzo","year":"2014","unstructured":"Scavuzzo A, Rios ZAS, Nover\u00f3n NR, R\u00edos MAJ (2014) Growing teratoma syndrome. Case Rep Urol 15(2):205\u2013208. https:\/\/doi.org\/10.1155\/2014\/139425","journal-title":"Case Rep Urol"},{"issue":"1","key":"6207_CR16","doi-asserted-by":"publisher","first-page":"75","DOI":"10.4103\/jcrt.JCRT_568_19","volume":"17","author":"Y Acikgoz","year":"2021","unstructured":"Acikgoz Y, Bal O, Ergun Y, Oksuzoglu B, Yildiz B, Do\u01e7an M (2021) Systemic treatment options for growing teratoma syndrome: a single-center experience with a comprehensive review of the literature. J Cancer Res Ther 17(1):75\u201379. https:\/\/doi.org\/10.4103\/jcrt.JCRT_568_19","journal-title":"J Cancer Res Ther"},{"issue":"3","key":"6207_CR17","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1055\/s-0042-1744519","volume":"32","author":"S Prineethi","year":"2022","unstructured":"Prineethi S, Irodi A, Eapen A, Milton S, Joel A (2022) Growing teratoma syndrome-a clinicoradiological series. Indian J Radiol Imaging 32(3):301\u2013307 https:\/\/doi.org\/10.1055\/s-0042-1744519","journal-title":"Indian J Radiol Imaging"},{"issue":"12","key":"6207_CR18","doi-asserted-by":"publisher","first-page":"13256","DOI":"10.1002\/cam4.6017","volume":"12","author":"MY Hsieh","year":"2023","unstructured":"Hsieh MY et al (2023) A case series and literature review on 98 pediatric patients of germ cell tumor developing growing teratoma syndrome. Cancer Med 12(12):13256\u201313269 https:\/\/doi.org\/10.1002\/cam4.6017","journal-title":"Cancer Med"},{"issue":"1","key":"6207_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0022-5347(17)54375-X","volume":"126","author":"BI Carr","year":"1981","unstructured":"Carr BI, Gilchrist KW, Carbone PP (1981) The variable transformation in metastases from testicular germ cell tumors: the need for selective biopsy. J Urol 126(1):52\u201354. https:\/\/doi.org\/10.1016\/S0022-5347(17)54375-X","journal-title":"J Urol"},{"issue":"3","key":"6207_CR20","first-page":"346","volume":"49","author":"PJ DiSaia","year":"1977","unstructured":"DiSaia PJ, Saltz A, Kagan AR, Morrow CP (1977) Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol 49(3):346\u2013350","journal-title":"Obstet Gynecol"},{"key":"6207_CR21","doi-asserted-by":"crossref","unstructured":"Hong WK, Wittes RE, Hajdu ST, Cvitkovic E, Whitmore WF, Golbey RB (1977) The evolution of mature teratoma from malignant testicular tumors; volume40; pages 2987-2992; DOI: 10.1002\/1097-0142(197712)40:6<2987::aid-cncr2820400634>3.0.co;2-a","DOI":"10.1002\/1097-0142(197712)40:6<2987::AID-CNCR2820400634>3.0.CO;2-A"},{"key":"6207_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216673","author":"P Pongratanakul","year":"2024","unstructured":"Pongratanakul P (2024) Assessing the risk to develop a growing teratoma syndrome based on molecular and epigenetic subtyping as well as novel secreted biomarkers. Cancer Lett https:\/\/doi.org\/10.1016\/j.canlet.2024.216673","journal-title":"Cancer Lett"},{"key":"6207_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3348\/kjr.2020.1391","volume":"22","author":"DB Green","year":"2021","unstructured":"Green DB, La Rosa FG, Craig PG, Khani F, Lam ET (2021) Metastatic mature teratoma and growing teratoma syndrome in patients with testicular non-seminomatous germ cell tumors. Korean J Radiol 22:1\u20138. https:\/\/doi.org\/10.3348\/kjr.2020.1391","journal-title":"Korean J Radiol"},{"key":"6207_CR24","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.1016\/j.wneu.2019.10.074","volume":"134","author":"S Tsuyuguchi","year":"2020","unstructured":"Tsuyuguchi S et al (2020) Primary and recurrent growing teratoma syndrome in central nervous system nongerminomatous germ cell tumors: case series and review of the literature. World Neurosurg 134:e360\u2013e371 https:\/\/doi.org\/10.1016\/j.wneu.2019.10.074","journal-title":"World Neurosurg"},{"key":"6207_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.04.010","volume-title":"European association of urology guidelines on testicular cancer: 2023 update","author":"A Patrikidou","year":"2023","unstructured":"Patrikidou A et al European association of urology guidelines on testicular cancer: 2023 update. Eur Urol https:\/\/doi.org\/10.1016\/j.eururo.2023.04.010"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06207-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06207-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T16:40:00Z","timestamp":1781628000000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06207-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6207"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06207-5","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"23 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"88"}}